Expression of TUBA1A in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

TUBA1A is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3775.44

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3672.8

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	10739.2
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	10479.4
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	10149.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	9353.9
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	8717.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	8020.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	7976.9
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	7180.2
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	6768.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	6539.5
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	6444.3
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	6107.1
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	5926.8
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	5885.8
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	5847.7
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	5805.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	5593.7
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	5556.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	5329.0
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	5179.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	5161.1
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	5057.3
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	5039.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	5025.4
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	5013.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	4989.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	4933.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	4927.9
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	4832.9
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	4731.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4717.6
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	4665.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	4562.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	4474.8
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	4365.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	4340.0
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	4283.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	4263.0
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	4261.8
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	4255.9
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	4224.5
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	4146.5
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4087.8
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	4063.7
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	4047.5
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	3994.0
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3967.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	3955.3
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3897.8
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	3872.2
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3858.9
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	3804.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	3797.4
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	3792.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	3758.9
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	3740.1
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3715.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3700.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	3684.2
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	3675.9
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	3626.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3626.2
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	3617.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3604.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	3589.2
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	3536.4
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	3521.7
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	3490.5
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	3477.9
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3455.7
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	3453.2
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3426.2
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3422.7
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3415.4
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	3373.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3357.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3303.6
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	3283.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3253.1
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	3182.5
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	3116.9
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	3110.4
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	3100.8
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	3077.6
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3072.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	3051.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2977.7
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2960.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2956.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2930.6
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	2909.7
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2896.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2895.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2860.3
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	2745.0
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2734.4
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2591.5
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2541.8
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	2532.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2499.0
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2497.2
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2488.4
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2431.7
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2427.3
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2383.6
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2360.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2324.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2308.0
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2307.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2290.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2244.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2220.8
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	2211.2
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	2201.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2199.4
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2172.1
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2147.6
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2138.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	2115.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2111.4
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2071.0
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	2045.3
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2042.3
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	2031.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2030.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1878.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1815.4
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1679.6
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1632.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1626.5
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1570.3
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1505.5
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1487.0
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1134.2
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1087.7
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	963.8
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	909.0
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	843.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	728.4
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	681.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	663.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

TUBA1A is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2172.05

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2797.7

Number of samples

Samples

Sample	Description	pTPM
AK068	N, NA, stage:NA, alive, 360 days	5798.8
AK156	N, NA, stage:NA, dead, 330 days	5713.6
AK165	N, NA, stage:NA, alive, 360 days	5584.7
AK006	N, NA, stage:NA, dead, 360 days	4763.6
AK199	N, NA, stage:NA, alive, 1860 days	4710.9
AK231	N, NA, stage:NA, dead, 240 days	4624.9
AK153	N, NA, stage:NA, dead, 240 days	4545.3
AK003	N, NA, stage:NA, dead, 600 days	4419.5
AK049	N, NA, stage:NA, dead, 180 days	4404.8
AK076	N, NA, stage:NA, alive, 660 days	4081.1
AK051	N, NA, stage:NA, dead, 360 days	4055.3
AK053	N, NA, stage:NA, dead, 300 days	3991.3
AK072	N, NA, stage:NA, dead, 150 days	3884.2
AK002	N, NA, stage:NA, dead, 570 days	3727.7
AK134	N, NA, stage:NA, dead, 360 days	3704.9
AK074	N, NA, stage:NA, alive, 300 days	3647.6
AK142	N, NA, stage:NA, alive, 90 days	3359.0
AK071	N, NA, stage:NA, dead, 540 days	3316.1
AK124	N, NA, stage:NA, alive, 1920 days	3253.3
AK149	N, NA, stage:NA, dead, 420 days	3241.8
AK079	N, NA, stage:NA, dead, 210 days	3241.8
AK183	N, NA, stage:NA, alive, 360 days	3174.0
AK213	N, NA, stage:NA, alive, 2010 days	3008.6
AK123	N, NA, stage:NA, dead, 180 days	2888.8
AK173	N, NA, stage:NA, dead, 180 days	2848.0
AK158	N, NA, stage:NA, dead, 360 days	2707.9
AK218	N, NA, stage:NA, dead, 180 days	2702.6
AK085	N, NA, stage:NA, alive, 660 days	2689.8
AK236	N, NA, stage:NA, dead, 360 days	2689.7
AK035	N, NA, stage:NA, dead, 210 days	2555.5
AK117	N, NA, stage:NA, dead, 210 days	2524.1
AK043	N, NA, stage:NA, alive, 660 days	2467.8
AK216	N, NA, stage:NA, dead, 360 days	2376.9
AK055	N, NA, stage:NA, dead, 240 days	2316.3
AK081	N, NA, stage:NA, dead, 180 days	2248.3
AK066	N, NA, stage:NA, alive, 960 days	2095.8
AK100	N, NA, stage:NA, alive, 960 days	2074.0
AK133	N, NA, stage:NA, dead, 360 days	2045.4
AK195	N, NA, stage:NA, dead, 390 days	2040.9
AK041	N, NA, stage:NA, alive, 810 days	2002.6
AK178	N, NA, stage:NA, dead, 240 days	1900.5
AK098	N, NA, stage:NA, dead, 660 days	1852.5
AK089	N, NA, stage:NA, dead, 330 days	1809.6
AK015	N, NA, stage:NA, alive, 720 days	1782.6
AK167	N, NA, stage:NA, dead, 180 days	1768.5
AK227	N, NA, stage:NA, alive, 300 days	1754.6
AK005	N, NA, stage:NA, dead, 240 days	1709.5
AK030	N, NA, stage:NA, dead, 120 days	1637.6
AK139	N, NA, stage:NA, dead, 270 days	1578.2
AK102	N, NA, stage:NA, alive, 1740 days	1544.5
AK099	N, NA, stage:NA, dead, 420 days	1516.3
AK088	N, NA, stage:NA, dead, 360 days	1451.7
AK091	N, NA, stage:NA, dead, 210 days	1440.0
AK226	N, NA, stage:NA, dead, 360 days	1298.1
AK188	N, NA, stage:NA, alive, 420 days	1216.6
AK103	N, NA, stage:NA, alive, 1320 days	1175.2
AK185	N, NA, stage:NA, alive, 330 days	834.4
AK205	N, NA, stage:NA, dead, 120 days	473.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204370003	Normal	1.1
CPT0204360003	Normal	1.0
CPT0204390003	Normal	1.0
CPT0204420003	Normal	1.0
CPT0204400003	Normal	1.0
CPT0204340003	Normal	1.0
CPT0204330003	Normal	1.0
CPT0204410003	Normal	0.9
CPT0204380003	Normal	0.9
CPT0204350003	Normal	0.9
CPT0196850003	Tumor	0.6
CPT0206450003	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0218770003	Tumor	0.4
CPT0217880003	Tumor	0.4
CPT0206110003	Tumor	0.3
CPT0104220003	Tumor	0.3
CPT0162100003	Tumor	0.2
CPT0087730003	Tumor	0.2
CPT0206880003	Tumor	0.2
CPT0189460003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0225760003	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0206330003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0087680003	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0205450004	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0189750004	Tumor	N/A
CPT0162020003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0168720003	Tumor	0.0
CPT0104330003	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0217060003	Tumor	0.0
CPT0217100003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0079790003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0162140003	Tumor	-0.2
CPT0225730003	Tumor	-0.2
CPT0168830003	Tumor	-0.2
CPT0208980003	Tumor	-0.2
CPT0189570004	Tumor	-0.2
CPT0093590003	Tumor	-0.2
CPT0205780003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0161730003	Tumor	-0.2
CPT0168480003	Tumor	-0.2
CPT0218690004	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0087570003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0186100003	Tumor	-0.2
CPT0168590003	Tumor	-0.2
CPT0002410011	Tumor	-0.2
CPT0123530003	Tumor	-0.3
CPT0218960004	Tumor	-0.3
CPT0093510003	Tumor	-0.3
CPT0064890003	Tumor	-0.3
CPT0206000004	Tumor	-0.3
CPT0216920008	Tumor	-0.3
CPT0217710008	Tumor	-0.3
CPT0093550003	Tumor	-0.3
CPT0071100003	Tumor	-0.3
CPT0167640003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0167750004	Tumor	-0.3
CPT0206230003	Tumor	-0.3
CPT0224600003	Tumor	-0.3
CPT0228220003	Tumor	-0.3
CPT0167860004	Tumor	-0.3
CPT0167530003	Tumor	-0.3
CPT0224390004	Tumor	-0.4
CPT0127420003	Tumor	-0.4
CPT0078580003	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0206560003	Tumor	-0.4
CPT0207090003	Tumor	-0.5
CPT0224540004	Tumor	-0.5
CPT0171580008	Tumor	-0.5
CPT0218330004	Tumor	-0.5
CPT0218830004	Tumor	-0.5
CPT0127480003	Tumor	-0.6
CPT0093450003	Tumor	-0.6
CPT0217430008	Tumor	-0.6
CPT0168080003	Tumor	-0.8
CPT0206670004	Tumor	-0.9
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA039247	Antibody HPA043684	Antibody HPA063394	Antibody CAB008686
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade